While the development of a COVID-19 vaccine could generate billions of dollars for some pharmaceutical companies such as Pfizer, concerns over accusations of exploiting the pandemic will likely temper profits, experts suggest. "This is a perfect time for [pharmaceutical companies] to develop their brand equity, which will serve them well for longer -term profits. "I think they think it's appropriate to get back the investment they made. "We do believe that the Pfizer vaccine will generate profits for Pfizer in 2021, but we haven't made an explicit estimate of that profit," he said. Some companies, including Johnson & Johnson, have pledged they will not profit from their vaccine for the course of the pandemic.
Source: CBC News November 25, 2020 16:52 UTC